title: An immunohistochemical study of E-cadherin expression in human squamous cell carcinoma of the skin: relationship between decreased expression of E-cadherin in the primary lesion and regional lymph node metastasis.
abstract: E-cadherin is a Ca(2+)-dependent, intercellular adhesion molecule that is specifically expressed in epithelial tissues and is essential for maintaining intercellular connections. It has been reported that E-cadherin expression of tumor cells is often decreased in some types of metastasizing carcinomas as compared with those without metastasis. We immunohistochemically examined the expression of E-cadherin with anti-E-cadherin monoclonal antibody and compared primary lesions of human squamous cell carcinoma of the skin (SCC) with regional lymph node metastasis to those without regional lymph node metastasis. Tumor samples from fifty-five cases of SCC (32 cases of SCC without metastasis and 23 cases with metastasis) were formalin-fixed, paraffin-embedded, and examined. E-cadherin was reduced or absent in 39 (70.9%) out of 55 cases of SCC, and in 21 (91.3%) of 23 cases with regional lymph node metastasis. Our results suggest that the decreased expression of E-cadherin in the primary lesion is correlated with regional lymph node metastasis in SCC and that it is more frequently correlated with well-differentiated than with poorly differentiated SCC. E-cadherin may be useful as a marker for metastatic potential in well-differentiated SCC.
authors.affiliation: Department of Dermatology, Yamagata University School of Medicine, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Koseki
authors.forename: T
authors.initials: T
authors.lastname: Aoki
authors.forename: S
authors.initials: S
authors.lastname: Ansai
authors.forename: Y
authors.initials: Y
authors.lastname: Hozumi
authors.forename: Y
authors.initials: Y
authors.lastname: Mitsuhashi
authors.forename: S
authors.initials: S
authors.lastname: Kondo
mesh_terms: D015100:3,3'-Diaminobenzidine / Q000737:chemistry; D000911:Antibodies, Monoclonal; D015820:Cadherins / Q000032:analysis* / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000235:genetics / Q000473:pathology / Q000556:secondary*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D007150:Immunohistochemistry; D008207:Lymphatic Metastasis; D011379:Prognosis; D012878:Skin Neoplasms / Q000235:genetics / Q000473:pathology*
chemical_list: D000911:Antibodies, Monoclonal; D015820:Cadherins; D015100:3,3'-Diaminobenzidine